1 Min Read
Feb 13 (Reuters) - Ipsen Sa:
* IPSEN BIOPHARMACEUTICALS CANADA SAYS HEALTH CANADA APPROVES SOMATULINE AUTOGEL (LANREOTIDE INJECTION) 120 MG FOR TREATMENT OF CARCINOID SYNDROME Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.